(Date:11/30/2009)... , , SEATTLE, Nov. 30 /PRNewswire-F... and MTA: CTIC) announced today that its new class...s-platinates, demonstrated a stronger anti-tumor p...e platinum-based compounds as well as the ability ...nes. The results were presented in a paper titled...
(Date:11/30/2009)... , , SHANGHAI, Nov. 30 /PRNewswi...ng pharmaceutical, biotechnology, and medical-devi...th operations in China and the United States,anno...chnology Fast 50 China,2009 list for the fifth con...growing companies in China,s technology, media, an...
(Date:11/30/2009)... , , AMSTERD..., the world,s,leading publisher of scientific, med...nounced a major re-launch of Embase, its comprehen...on indexed records from more than 7,000,active, pe...layed a key role in the advancement of new biomedi...
(Date:11/28/2009)... , The Vanuatu National A...h its Second National Communication (SNC) Project ...ervices and CLIMsystems Ltd. of New Zealand have g...rise results that will form the background for the...ns Framework Convention on Climate Change (UNFCCC)...
Breaking Biology Technology:New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year 2Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 2Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 3Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 2Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 3Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 4(Date:11/30/2009)...PRNewswire-FirstCall/ -- NightHawk Radiology Servi...o radiology groups and hospitals throughout the Un...Assurance (QA) program to foster better communicat... and to deliver superior patient care. ,, Nig... program in several presentations at RSNA 2009. Ni...
(Date:11/30/2009)...re/ -- Reportlinker.com announces that a new marke..., Surgical Incision Closures - Global Trends ...al-Incision-Closures---Global-Trends.html ,, S...gnificance, due to the millions of surgical proced...es such as cardiology, obstetrics/gynecology, orth...
(Date:11/30/2009)...RNewswire/ -- Cytokine PharmaSciences, Inc. today ...I-2364, its orally active, small-molecule inhibito...lammatory cytokines. Results of the safety and to...eers confirm the safety of this compound in initia...ts completed the study, including those receiving ...
Breaking Medicine Technology:NightHawk Radiology Launches Redesigned Quality Assurance Program 2Reportlinker Adds Surgical Incision Closures - Global Trends 2Reportlinker Adds Surgical Incision Closures - Global Trends 3Reportlinker Adds Surgical Incision Closures - Global Trends 4Reportlinker Adds Surgical Incision Closures - Global Trends 5Reportlinker Adds Surgical Incision Closures - Global Trends 6Reportlinker Adds Surgical Incision Closures - Global Trends 7Cytokine PharmaSciences Completes Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364 2Young leukemia and lymphoma patients live longer today than in years past 55090 1Young leukemia and lymphoma patients live longer today than in years past 55090 2The Eli and Edythe Broad Foundation recommit to gastroenterologys future 55086 1The Eli and Edythe Broad Foundation recommit to gastroenterologys future 55086 2U M researchers discover therapeutic target that could help patients with pulmonary fibrosis 55083 1U M researchers discover therapeutic target that could help patients with pulmonary fibrosis 55083 2